Ali Soleymannezhad

Chief Commercial Officer Cellares Corporation

Seminars

Wednesday 16th September 2026
Delivering Commercial-Ready Cell Therapies at Scale through a Global Network of Smart Factories
8:55 am
  • Case study: successful manufacturing of a clinical-stage CAR-T drug product using the Cellares Cell Shuttle
  • Breaking the QC bottleneck with high-throughput, digitally integrated release testing via Cell Q
  • Standardizing automation-native facility design across the US, EU, and Japan
Ali Soleymannezhad - Cellares - Expert Speaker at the 11th CAR-TCR Summit 2026